Randomized Trial of Trust in Online Videos About Prostate Cancer
April 23, 2024 updated by: NYU Langone Health
The study team will evaluate the impact of video characteristics on health consumers' trust in online videos.
Participants will be randomized to watch a video by one of four speakers about prostate cancer screening or clinical trials and complete a questionnaire (approximately 15 minutes total).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Other: Black Doctor Screening Video
- Other: White Doctor Screening Video
- Other: Black Patient Screening Video
- Other: White Patient Screening Video
- Other: Black Doctor Clinical Trials Video
- Other: White Doctor Clinical Trials Video
- Other: Black Patient Clinical Trials Video
- Other: White Patient Clinical Trials Video
Study Type
Interventional
Enrollment (Actual)
3649
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- US adult age 40+
- Enrolled in Dynata online survey panel
Exclusion Criteria:
- Children
- Individuals living outside the U.S.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Video About Screening with Black Doctor
|
Participants will view an online video with a Black doctor speaking about prostate cancer screening.
|
|
Experimental: Video About Screening with White Doctor
|
Participants will view an online video with a White doctor speaking about prostate cancer screening.
|
|
Experimental: Video About Screening with Black Patient
|
Participants will view an online video with a Black patient speaking about prostate cancer screening.
|
|
Experimental: Video About Screening with White Patient
|
Participants will view an online video with a White patient speaking about prostate cancer screening.
|
|
Experimental: Video about Clinical Trials with Black Doctor
|
Participants will view an online video with a Black doctor speaking about prostate cancer clinical trials.
|
|
Experimental: Video about Clinical Trials with White Doctor
|
Participants will view an online video with a White doctor speaking about prostate cancer clinical trials.
|
|
Experimental: Video about Clinical Trials with Black Patient
|
Participants will view an online video with a Black patient speaking about prostate cancer clinical trials.
|
|
Experimental: Video about Clinical Trials with White Patient
|
Participants will view an online video with a White patient speaking about prostate cancer clinical trials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of Trust in the Video
Time Frame: Visit 1 (Day 1)
|
Trust will be reported as a score on a Likert scale and asked as the following question: How much do you trust the information in the video?
The total range of score is 1-4, where (1) trust the information completely, (2) trust most of the information, (3) trust some of the information, (4) do not trust the information
|
Visit 1 (Day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stacy Loeb, MD, MSc, PhD(hc), NYU Langone Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 18, 2021
Primary Completion (Actual)
January 7, 2022
Study Completion (Actual)
January 7, 2022
Study Registration Dates
First Submitted
May 24, 2023
First Submitted That Met QC Criteria
May 24, 2023
First Posted (Actual)
June 2, 2023
Study Record Updates
Last Update Posted (Actual)
April 26, 2024
Last Update Submitted That Met QC Criteria
April 23, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-00540
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual participant data needed for the proposed biomedical research use according to data use agreement from both parties will be shared.
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
IPD Sharing Access Criteria
The investigator who proposed to use the data after signing a data use agreement will have access to the data upon reasonable request for biomedical research purposes.
Requests should be directed to stacy.loeb@nyulangone.org.
To gain access, data requestors will need to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.